openPR Logo
Press release

Global Peptic Ulcer Drugs Market Size To Expand At A Moderate CAGR Of 3.8% During The Forecast Period Of 2016-2022

02-11-2020 11:18 AM CET | Health & Medicine

Press release from: Market Research Future

Global Peptic Ulcer Drugs Market Size To Expand At A Moderate CAGR

Peptic Ulcer Drugs Market Overview:

Advancement in technology is aiding the pharmaceutical sector for development of highly effective drugs that are used for treating multiple disorders. Peptic ulcer drugs are used to treat the ulcer caused due to imbalance between defensive and aggressive fluids in the stomach. Market Research Future (MRFR) has published a report stating that the global peptic ulcer drugs market is marked to expand at a moderate CAGR of 3.8% during 2016-2022 and reach the valuation of USD 36.27 Bn by the end of 2022 from USD 29 Bn in 2015.

Get Free Sample copy @ https://www.marketresearchfuture.com/sample_request/2445

Peptic Ulcer Drugs Market Drivers and Restraints:

Changing lifestyle and food habits are majorly affecting the healthy functioning of gastric fluids, causing imbalance, which is then leading to various disorder such as ulcers. Increasing prevalence of lifestyle induced disorders and availability of effective drugs for treating such disorders are majorly fueling the expansion of the global peptic ulcer drugs market. Utilization of advanced technology for process automation of drug development in pharmaceutical industries and increase in research and development expenditure are some other factors that are propelling the growth of the global peptic ulcer drugs market. On the flip side, poor primary health care services and lack of awareness among the population in the underdeveloped regions are likely to pose a threat for the expansion of the global peptic ulcer drugs market during the forecast period.

Peptic Ulcer Drugs Market Segmentation:

The global peptic ulcer drugs market is segmented on the basis of pharmacological class and clinical application. Based on pharmacological class, the global peptic ulcer drugs market has been segmented into proton pump inhibitors (PPIs), anti-histamines, H2 antagonists, antacids, antibiotics and others. With respect to market valuation, the proton pump inhibitors (PPIs) segment is anticipated to project dominance over the global peptic ulcer drugs market during the forecast period. Based on clinical application, the global peptic ulcer drugs market has been segmented into gastric ulcers, duodenal ulcers and esophageal ulcer.

Peptic Ulcer Drugs Market Regional Analysis:

Geographically, the global peptic ulcer drugs market has been segmented into four major regions such as North America, Asia Pacific, Europe, and the Middle East and Africa. The North America region is projected to be the largest market for peptic ulcer drugs owing to the rapid adoption of advanced technology and automation of processes for drug manufacturing in pharmaceutical industry and increasing prevalence of ulcer and other intestinal disorders as a result of changing lifestyle and unhealthy food habits in this region. The peptic ulcer drugs market in the Europe region is projecting to expand at a significant growth rate during the forecast period owing to the increased research activities for the development of more effective drugs to cure peptic ulcers.

The Asia Pacific region is anticipated to expand at the fastest growth rate in the global peptic ulcer drugs market owing to the increasing demand for high-quality drugs to cure intestinal disorders and rapid development of healthcare sector in the emerging economies of this region. The Middle East and Africa region is projecting steady growth in the global peptic ulcer drugs market owing to the lack of awareness and poor healthcare facilities in the underdeveloped areas of this region.

Industry Updates:

In March 2018, Zydus Cadila, an Indian pharmaceutical company, has announced that it has received approval from US Food and Drug Administration (FDA) for marketing their new drugs, Omeprazole and Sodium bicarbonates capsules, that are used for treating esophagus and stomach problems such as peptic ulcers.

In February 2018, Stride Shasun, a key player in the U.S. Ranitidine market, has announced that it has decided to launch the over the counter version of intestinal and stomach ulcer drugs in 150 mg dosage which is now available for purchase in the U.S. market.

Key players:

The key players profiled by MRFR that are operating in the global peptic ulcer drugs market are Novartis AG, Daiichi Sankyo Company Limited, Actelion Ltd, Boehringer Ingelheim, Sanofi S.A., Astra Zeneca plc, Ranbaxy Laboratories Limited, Inc., Takeda Pharmaceuticals Company Limited, Pfizer Inc. Helicure AB and Eumedica Pharmaceuticals

Read More @ https://www.marketresearchfuture.com/reports/peptic-ulcer-drugs-market-2445

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Peptic Ulcer Drugs Market Size To Expand At A Moderate CAGR Of 3.8% During The Forecast Period Of 2016-2022 here

News-ID: 1927362 • Views:

More Releases from Market Research Future

US Color Cosmetics Market Report Presents an Overall Analysis, Development Trends, Driving Forces, Opportunities
US Color Cosmetics Market Report Presents an Overall Analysis, Development Trend …
Color cosmetics have long been an integral part of American culture, offering a wide range of products to enhance beauty and express individuality. The US color cosmetics market is a dynamic and vibrant landscape, driven by evolving consumer preferences, innovative product offerings, and changing beauty trends. In this article, we explore the key drivers, trends, restraints, and opportunities shaping the US color cosmetics market. The US Color Cosmetics Market was valued
US Takeout Containers Market Key Players, End User Demand and Analysis Growth Trends by 2032
US Takeout Containers Market Key Players, End User Demand and Analysis Growth Tr …
Takeout containers have become an integral part of the modern dining experience, offering convenience and portability for consumers on-the-go. In the United States, the takeout containers market has witnessed significant growth in recent years, driven by changing consumer lifestyles, the rise of food delivery services, and increasing environmental concerns. This article explores the key trends, drivers, restraints, and opportunities shaping the US takeout containers market. US Takeout Containers Market size was
Construction IoT Market Size with Growth Opportunities, Top Countries Data, Future Trends and Share with Revenue Forecast 2024 to 2032
Construction IoT Market Size with Growth Opportunities, Top Countries Data, Futu …
The Construction Internet of Things (IoT) market is rapidly expanding, revolutionizing the construction industry by enhancing productivity, safety, and efficiency. IoT in construction involves the use of sensors, devices, and software to collect and analyze data in real-time, enabling better decision-making and optimization of construction processes. The Construction IoT Market is estimated at US$ 51.78 billion in 2032 and is forecasted to increase rapidly at a CAGR of 16.8% from 2024
Logistics & Supply Chain Market By Business Top Key Players, Growth, Trend, Segmentation, Revenue and Industry Expansion Forecast Report
Logistics & Supply Chain Market By Business Top Key Players, Growth, Trend, Segm …
The logistics and supply chain market is a critical backbone of global commerce, ensuring the seamless flow of goods from production to consumption. It encompasses a vast network of processes, technologies, and providers working together to deliver products to customers efficiently and cost-effectively. Logistics & Supply Chain Market was valued at USD 9.1 Billion in 2024 and is expected to reach USD 14.72 Billion by 2032, registering a CAGR of 6.20%

All 5 Releases


More Releases for Peptic

Rapid digitization to drive the Peptic Ulcer Drugs Market
The Peptic Ulcer Drugs Market is expected to grow by leaps and bounds in the forecast period. Nanotechnology’s medical application is on the anvil. As such, nanomedicine is an outcome of the technology operating at the molecular, atomic, or supramolecular scale. The broad application areas of nanomedicine include sensing, imaging, diagnosis, and delivery via medical devices. This would certainly keep the healthcare vertical upgraded continuously. Surge in the consumption of NSAIDs
Peptic Ulcer Market Shares, Strategies, and Forecasts Analysis
Sores that develop on the lining of stomach, esophagus, and intestines are called peptic ulcers. Symptoms of peptic ulcers include vomiting, burning stomach pain, bloating, and food intolerance. These can be of three types: gastric ulcers, duodenal ulcers, and esophageal ulcers. Some of the causes of peptic ulcers are stomach infections caused by H. pylori, alcoholism, stomach cancers, usage of anti-inflammatory drugs such as aspirin, and smoking. Peptic ulcers, if
Anti-Peptic Ulcer Drugs Market Development in 2019
Global Anti-Peptic Ulcer Drugs Market report is designed in a method that helps readers to acquire a complete knowledge about the overall market scenario for the projected period. This Market report consists of the brief profile of key players in the industry and their upcoming market plans and current developments during the forecasted period 2019 to 2025. The report of global Anti-Peptic Ulcer Drugs market includes the competitive landscape section
Global Peptic Ulcers Treatment Sales Market Report 2018
Peptic Ulcers Treatment Market report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data. Global Peptic Ulcers Treatment Market, provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Peptic Ulcers Treatment Market analysis is provided for the international Industry including development trends, competitive landscape analysis,
Anti Peptic Ulcer Drugs Market Trends & Forecast to 2022
HTF MI published a new industry research that focuses on Anti Peptic Ulcer Drugs market and delivers in-depth market analysis and future prospects of Global Anti Peptic Ulcer Drugs market. The study covers significant data which makes the research document a handy resource for managers, analysts, industry experts and other key people get ready-to-access and self-analyzed study along with graphs and tables to help understand market trends, drivers and market
Anti Peptic Ulcer Drugs Market Analysis & Trends 2024
The global market for anti-peptic ulcer drugs is expected to grow at a progressive rate in the coming years, thanks to the rising awareness among patients regarding the easy availability of effective drugs. Moreover, the rising preference of patients to consume drugs instead of surgical procedure is expected to encourage the drug manufacturers to develop novel drugs in the coming years. The product segmentation, applications, technological developments, and the key